PROJECT OVERVIEW
The task 'Assessing the safety of Measles vaccine produced by POLYVAC through the pharmacovigilance system' was conducted in 2022 at the Center for Research and Production of Vaccines and Biologicals (POLYVAC).
Research Details
- TOPIC NAME Assessing the safety of measles vaccines produced by POLYVAC through pharmacovigilance system activities
- Name of the principal MSc. Lê Thu Nga, Quality Assurance Department
- Classification Grassroots-level scientific research topic
- Execution time 2022
Project/Topic Results
Supplemental Information
Providing supplemental information on Measles vaccine safety for the manufacturer
Related Studies
